4.58
-0.45 (-8.95%)
| Previous Close | 5.03 |
| Open | 4.99 |
| Volume | 43,589 |
| Avg. Volume (3M) | 18,081 |
| Market Cap | 168,600,784 |
| Price / Sales | 38.14 |
| Price / Book | 3.31 |
| 52 Weeks Range | |
| Earnings Date | 27 Feb 2025 - 3 Mar 2025 |
| Operating Margin (TTM) | -3,917.27% |
| Diluted EPS (TTM) | -5.34 |
| Quarterly Revenue Growth (YOY) | -27.40% |
| Total Debt/Equity (MRQ) | 4.68% |
| Current Ratio (MRQ) | 3.67 |
| Operating Cash Flow (TTM) | -67.20 M |
| Levered Free Cash Flow (TTM) | -48.03 M |
| Return on Assets (TTM) | -135.31% |
| Return on Equity (TTM) | -263.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | ANTERIS CDI 1:1 [AVR] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.25 |
|
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Institutions | 5.35% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |